<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13(5)</volume><submitter>Sabtcheva S</submitter><pubmed_abstract>Carbapenemase-producing &lt;i>Enterobacter&lt;/i> spp. &lt;i>Serratia marcescens&lt;/i>, &lt;i>Citrobacter freundii&lt;/i>, &lt;i>Providencia&lt;/i> spp., and &lt;i>Morganella morganii&lt;/i> (CP-ESCPM) are increasingly identified as causative agents of nosocomial infections but are still not under systematic genomic surveillance. In this study, using a combination of whole-genome sequencing and conjugation experiments, we sought to elucidate the genomic characteristics and transferability of resistance genes in clinical CP-ESCPM isolates from Bulgaria. Among the 36 sequenced isolates, NDM-1 (12/36), VIM-4 (11/36), VIM-86 (8/36), and OXA-48 (7/36) carbapenemases were identified; two isolates carried both NDM-1 and VIM-86. The majority of carbapenemase genes were found on self-conjugative plasmids. IncL plasmids were re</pubmed_abstract><journal>Antibiotics (Basel, Switzerland)</journal><pagination>455</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11117914</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Genomic Characterization of Carbapenemase-Producing &lt;i>Enterobacter hormaechei&lt;/i>, &lt;i>Serratia marcescens&lt;/i>, &lt;i>Citrobacter freundii&lt;/i>, &lt;i>Providencia stuartii&lt;/i>, and &lt;i>Morganella morganii&lt;/i> Clinical Isolates from Bulgaria.</pubmed_title><pmcid>PMC11117914</pmcid><pubmed_authors>Stoikov I</pubmed_authors><pubmed_authors>Christova I</pubmed_authors><pubmed_authors>Lesseva M</pubmed_authors><pubmed_authors>Teneva D</pubmed_authors><pubmed_authors>Sabtcheva S</pubmed_authors><pubmed_authors>Ivanov IN</pubmed_authors><pubmed_authors>Donchev D</pubmed_authors><pubmed_authors>Dobreva E</pubmed_authors><pubmed_authors>Georgieva S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Genomic Characterization of Carbapenemase-Producing &lt;i>Enterobacter hormaechei&lt;/i>, &lt;i>Serratia marcescens&lt;/i>, &lt;i>Citrobacter freundii&lt;/i>, &lt;i>Providencia stuartii&lt;/i>, and &lt;i>Morganella morganii&lt;/i> Clinical Isolates from Bulgaria.</name><description>Carbapenemase-producing &lt;i>Enterobacter&lt;/i> spp. &lt;i>Serratia marcescens&lt;/i>, &lt;i>Citrobacter freundii&lt;/i>, &lt;i>Providencia&lt;/i> spp., and &lt;i>Morganella morganii&lt;/i> (CP-ESCPM) are increasingly identified as causative agents of nosocomial infections but are still not under systematic genomic surveillance. In this study, using a combination of whole-genome sequencing and conjugation experiments, we sought to elucidate the genomic characteristics and transferability of resistance genes in clinical CP-ESCPM isolates from Bulgaria. Among the 36 sequenced isolates, NDM-1 (12/36), VIM-4 (11/36), VIM-86 (8/36), and OXA-48 (7/36) carbapenemases were identified; two isolates carried both NDM-1 and VIM-86. The majority of carbapenemase genes were found on self-conjugative plasmids. IncL plasmids were re</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 May</publication><modification>2026-04-24T03:14:03.708Z</modification><creation>2026-04-24T03:09:38.719Z</creation></dates><accession>S-EPMC11117914</accession><cross_references><pubmed>38786183</pubmed><doi>10.3390/antibiotics13050455</doi></cross_references></HashMap>